Skip to content
Trial Eligibility
Menu

Evaluation of the Electronic Cigarette Withdrawal Syndrome

NCT06066996

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this project is to rigorously evaluate the nature of e-cigarette withdrawal in exclusive e-cigarette users during a monitored abstinence period and the role of nicotine in the expression of this withdrawal syndrome.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • E-cigarette Use
  • Withdrawal

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
21 to 55 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Johns Hopkins University
Last updated on ClinicalTrials.gov
July 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Behavioral Pharmacology Research Unit · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.